By 2023, Bayer's market value had declined by over 60% , leaving the entire company worth less than half of what it originally paid for Monsanto.
Following the merger, Bayer retired the "Monsanto" brand name , though product names like Roundup were kept as part of the Bayer portfolio . did bayer buy monsanto
In 2020, Bayer agreed to a settlement of up to $9.6 billion to resolve tens of thousands of pending claims, though many cases remain active in court today. Bayer closes Monsanto acquisition By 2023, Bayer's market value had declined by
To gain antitrust approval from the EU and U.S., Bayer was forced to sell significant portions of its own agriculture business, including seed and herbicide units, to its competitor BASF . Consequences of the Merger Bayer closes Monsanto acquisition To gain antitrust approval
Since the purchase, Bayer has faced over 165,000 lawsuits alleging that Monsanto's weedkiller, Roundup, causes non-Hodgkin lymphoma. This ongoing litigation has had a severe impact on the company:
The all-cash deal was valued at approximately $63 billion (initially announced as $66 billion).
The acquisition combined two of the world's largest agricultural companies, but it has since been widely criticized as one of the "worst corporate mergers in history" due to the massive legal liabilities Bayer inherited. Key Facts of the Acquisition